CareDx
CDNA
Performance
About CareDx
CareDx is a transplant-focused company delivering genomics-based products and solutions across pre- to post-transplant care. The company provides diagnostic and surveillance tools, including HLA typing services and digital transplant solutions, to support transplant decisions and patient management globally. Its portfolio includes lab products, transplant services, and digital health apps designed for clinicians, laboratories, and patients in the transplant ecosystem. CareDx is headquartered in the United States and emphasizes partnerships with transplant professionals, laboratories, and care teams to improve patient outcomes.
Recent News
CareDx to Acquire Naveris for $160M to Expand Into HPV-Driven Cancer MRD Monitoring
CareDx Q1 2026 Earnings: COO Keith Kennedy Highlights 39% Revenue Rise and $170 M Lab Divestiture
Theradaptive Receives US FDA Approval to Initiate P-III Trial of OsteoAdapt SP for Spinal Fusion Procedures
CareDx to Divest Lab Products Unit to EuroBio Scientific for $170M